Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-02-21FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ATACAND (candesartan cilexetil) filed by ANI Pharmaceuticals, Inc., updating its labeling.
-
FDA approval · 2013-02-20FDA Approved: LISINOPRIL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for lisinopril (Actavis Pharma, Inc.).
-
FDA approval · 2013-02-05FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. (ANDA 086513).
-
FDA approval · 2013-02-01FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2013-02-01FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc., authorizing a change …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-02-01FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) submitted by Cosette Pharmaceuticals,…
-
FDA approval · 2013-02-01FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) from Cosette Ph…
-
FDA approval · 2013-01-29FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Hydralazine Hydrochloride, marking an approved supplement to the product's existing approva…
-
FDA approval · 2013-01-28FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide (a generic combination therapy), submitted by NorthSt…
-
FDA approval · 2013-01-28FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for hydralazine hydrochloride from Teva Pharmaceuticals USA, Inc. (generic) under an Abbreviated New…
-
FDA approval · 2013-01-28FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approves a supplemental application for Losartan Potassium from Macleods Pharmaceuticals Limited (ANDA202230), authorizing the generic p…
-
FDA approval · 2013-01-17FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (TruPharma, LLC)
FDA approved a supplemental application for clonidine hydrochloride from TruPharma, LLC. This action indicates regulatory approval of a supp…
-
FDA approval · 2013-01-17FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for clonidine hydrochloride from Alembic Pharmaceuticals Limited.
-
FDA approval · 2013-01-17FDA Approved: FELODIPINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Original Application for Felodipine, authorizing the marketing of a generic felodipine product.
-
FDA approval · 2013-01-16FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride from Actavis Pharma, Inc., indicating an approved modification to an…
-
FDA approval · 2013-01-11FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for DURACLON (clonidine hydrochloride) from Mylan Institutional LLC, adding to the existing approved…
-
FDA approval · 2013-01-10FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Nicardipine hydrochloride from Hikma Pharmaceuticals USA Inc., granting regulatory approval …
-
FDA approval · 2013-01-07FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NORVASC (amlodipine besylate) submitted by Viatris Specialty LLC. The approval is related to…
-
FDA approval · 2012-12-21FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic Losartan Potassium product by Alembic Pharmaceuticals Limited.
-
FDA approval · 2012-12-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, resulting in approval of a generic losartan po…
-
FDA approval · 2012-12-19FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for BYSTOLIC (nebivolol hydrochloride) filed by Allergan, Inc.
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
FDA approved the supplemental application for Losartan Potassium 25 mg by Strides Pharma Science Limited, authorizing the generic product fo…
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA has approved Lupin Pharmaceuticals' supplemental application for Losartan Potassium, a generic product, via ANDA indicating an additiona…
-
FDA approval · 2012-12-17FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Quinapril from Cipla USA Inc., marking an additional regulatory action for this ACE inhibito…